Advertisement

Topics

Woodford-backed Prothena targeted by short seller Kerrisdale

04:36 EST 8 Nov 2017 | Reuters

LONDON (Reuters) - Hedge fund Kerrisdale Capital has taken a short position on drugmaker Prothena, a company backed by UK investor Neil Woodford, calling it "the next big biotech blowup".

Original Article: Woodford-backed Prothena targeted by short seller Kerrisdale

NEXT ARTICLE

More From BioPortfolio on "Woodford-backed Prothena targeted by short seller Kerrisdale"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...